Monday, 20 May 2019

Pharma News

  • Dr Brian McNamee to step down from CSL

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: After 23 years of being at the helm of CSL, Dr Brian McNamee will leave the firm in July 2013 and will be succeeded by Mr Paul Perreault, who is currently the president of CSL Be...Read more

  • TWi Pharma gets FDA nod for ADHD drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

    Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride extended release tablets 1mg, 2mg, 3...Read more

  • India's Science & Technology minister passes away

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2012

    Bangalore: Mr Vilasrao Deshmukh, the Science and Technology minister, Government of India, passed away at a hospital in Chennai this afternoon after a brief illness at the age of 67. He was...Read more

  • Takeda, M2Gen set to boost Health Informatics-based cancer treatment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2016

    Japanese pharma giant Takeda Pharmaceutical Company Limited and M2Gen, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic data from c...Read more

  • AnGes, Mitsubishi Tanabe sign MoU to market Collategene

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

  • Wockhardt to market generic of GSK Parkinson's drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2012

    Mumbai: Pharmaceutical and biotechnology major Wockhardt received US FDA approval for marketing 2mg, 4mg, 6mg, 8mg and 12mg extended-release tablets with generic version of GlaxoSmithKline'...Read more

  • 5 major policy developments of 2012

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • Udit Batra to head Merck-Sigma Aldrich merger firm

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2015

    Singapore: Mr Udit Batra, CEO and president of German firm, Merck's lifescience business, will be heading the business of Merck post acquisition of Sigma-Aldrich. The planned $17 billion t...Read more

  • 50 Indian companies to invest $500mn in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Hyderabad: 50 Indian companies have recently indicated they will collectively invest over $500 million in the US market by either acquiring a US business or setting up their own operations...Read more

  • Sandoz launches trial with Amgen biosimilar

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel. With this, Novartis has consolidated its leading position in...Read more

  • Lupin gets approval for oral contraceptive

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Bangalore: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its oral contraceptive Kurvelo® Tablets (Levo...Read more

  • WuXi, OMT join hands to develop OmniRat antibodies

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US, and Open Monoclonal Technol...Read more

  • Roche under EMA scanner for medicine safety

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jun, 2012

    Singapore: The European Medicines Agency is working with national medicines agencies to investigate deficiencies in the medicine-safety reporting system of Roche. This includes looking at w...Read more

  • Korean, Chinese firms sign depression drug deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: South Korean-based SK Biopharmaceuticals entered into a collaboration agreement with PKU International HealthCare, China, and Shanghai Medicilon, China, for its novel new small m...Read more

  • Boehringer Ingelheim enriches drug pipeline

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of a clinical-stage company, Funxional Therapeutics' FX125L compound and...Read more

  • Del Mar, Guangxi Wuzhou join hands for cancer drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Del Mar Pharmaceuticals announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group  for the developm...Read more

  • Regulatory officials salaries up by 5.4% in 2013'

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

    Singapore: Regulatory professionals' base salaries in US has increased by an average of 5.4 percent from 2012 to 2013, according to a survey by Regulatory Affairs Professionals Society (RAP...Read more

  • Merck prices $2.5 billion debt offering

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Merck & Co., has priced $2.5 billion public offering of senior unsecured notes. The notes include $1.0 billion of 1.100% notes due 2018, $1.0 billion of 2.400% notes due 2022...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls